CompuMed Reported Earnings

CompuMed (CMPD) reported earnings of $0.02 per share on revenue of $2.16 million for the . . Revenue grew 8.72% on a year-over-year basis.

COMPUMED, INC. is a medical systems company engaged primarily in the application of computer technology to medicine. The main aspects of Co.'s business are (i) the licensing of its proprietary technology in the OsteoGramR, a bone density test that was developed by the Company as a means of aiding physicians in diagnosing and monitoring osteoporosis, (ii) the computer interpretation of electrocardiograms, (iii) TeleCor Services Division, which is engaged in transtelephonic cardiac event monitoring.